Assessment of myocardial viability with 99mTc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty

Hellenic Journal of Nuclear Medicine

Volumn 8, Issue 1, 2005, Pages 48-53

  Tzonevska, Antonia ^a   Tzvetkov, Krasimir ^a   Dimitrova, Maria ^a   Piperkova, Elena ^a  

^a Clinic of Nuclear Medicine   (Bulgaria)

Author keywords

99mTc sestamibi; Gated SPET; Nitrate augmentation

Indexed keywords

GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSKINESIA; FATIGUE; FEMALE; FOLLOW UP; GATED IMAGING; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE WALL MOTION; HUMAN; HYPOKINESIA; IMAGE QUALITY; MALE; QUANTITATIVE ANALYSIS; REPERFUSION; RESTENOSIS; SCINTILLATION CAMERA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STABLE ANGINA PECTORIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; CORONARY ARTERIOSCLEROSIS; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PREOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 19444371500     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Braunwald E, Rutherford JD. Reversible left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 1986; 8: 1467-1470.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J1989; 117: 211-213.
3. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
4. Iskandrian AS, Hakki A, Kane SA, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 1983; 51: 1312-1316.
5. Brunken RC, Schwaiger M, Grover-McKay M, et al: Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557-567.
6. 201TI-reinjection and 18FFDG. Circulation 1994; 89: 578-587.
7. Dilsizian V, Rocco TP, Freedman NM, et al. Enhanced detection of ischemic but-viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med1990; 323: 141-146.
8. Cloninger KG, DePuey EG, Garcia EV, et al. Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring. J Am Coll Cardiol1988; 12: 955-963.
9. Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988; 12: 1456-1463.
10. Tamaki N, Ohtani H, Yonekura Y, et al. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990; 31: 1617-1623.
11. Rocco TP, Dilsizian V, McKusick KA, et al. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
12. Bonow RD, Dilsizian V, Cuocolo A, et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglutose. Circulation 1991; 83:26-37.
13. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
14. Freeman I, Grunwald AM, Hoory S, et al. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991; 32: 292-298.
15. Beanlands RS, Dawood F, Wen WH, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82: 1802-1814.
16. 201Tl in CAD. Eur J Nucl Med 1995; 22:1306-1312.
17. 99mTc-MIBI for assessment of viable myocardium. J Nucl Med 1992; 33: 815-817.
18. 99mTc-isonitrile: A perfusion or a viable agent? J Am Coll Card 1989; 14: 1685-1687.
19. 99mTc-MIBI myocardial perfusion imaging for detection of CAD. Eur J Nucl Med 1989; 15: 280-286.
20. 99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med 1988; 29: 1539-1548.
21. Sciagra R, Leoncini M; Mennuti A, et al. Classification of ischemic dysfunctional myocardium combining perfusion quantification and contractile reserve evaluation using nitrate-enhanced gated single photon emission computed tomography with dobutamine test. J Nucl Med Mol Imaging 2004; 48: 4-11.
22. Leoncini M, Marcucci G, Sciagra R, et al. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress. Am J Cardiol 2001; 87: 1346-1350.
23. Maurea S, Maurea S, Cuocolo A, et al. Enhanced detection of viable myocardium by Tc-99mMIBI imaging after nitrate administration in chronic CAD. J Nucl Med 1995; 36: 1945-1952.
24. Bisi G, Sciagra R, Santoro GM, et al. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995; 36: 1994-2000.
25. 99mTc-MIBI cardiac tomography after nitroglycerin administration in identification of viable myocardium (abstr). Eur J Nucl Med1994; 21: 735.
26. He ZX, Darcourt J, Guignier A, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993; 34:1472-1477.
27. He ZX, Verani MS, Liu XI. Nitrate-augmented evaluation of myocardial viability. J Nucl Cardiol 1995; 2: 352-357.
28. He ZX, Medrano R, Hays JT, et al. Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial. Circulation 1997; 95:1799-1805.
29. Galli M, Marcassa C, Imparato A, et al. Effects of nitroglycerin by technetium: 99m-sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994; 74: 843-848.
30. Bisi G, Sciagra R, Santoro GM, et al. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrate: feasibility and reliability for prediction of ostrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 24: 1282-1289.
31. Li ST, Liu XI, Lu ZL, et al. Myocardial tomography and isosorbide Tc-99m MIBI SPECT dinitrate infusion: a new method for assessment of myocardial viability. Chin J Nucl Med 1995; 15: 6-8.
32. Abrams J. Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J 1985; 110: 216-224.
33. Brown BG, Bolson E, Peterson RB, et al. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981; 64: 1089-1097.
34. Aoki M, Sakai K, Koyanagi S, et al. Effect of nitroglycerin on Coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991; 121: 1361-1366.
35. Cohn PF, Maddox D, Holman BL, et al. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 1977; 39: 672-678.
36. Fallen EL, Nahmias C, Scheffel A, et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995; 91: 1381-1388.
37. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994; 24: 25-32.
38. 99mTc sestamibi. Circulation 1994; 89: 2552-2561.
39. Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.
40. Senior R, Glenville B, Basu S, et al. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischemic left ventricular dysfunction. Br Heart J 1995; 74: 358-364.
41. Hachamovich R, Berman DS; Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
42. Hachamovich R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
43. Paeng J, Lee D, Kang W, et al. Time course of functional recovery after coronary artery bypass grafting surgery according to the preoperative reversibility of perfusion impairment on myocardial SPECT. Eur J Nucl Med Mol Imaging 2005; 32: 70-74.
44. Ellis SG. Elective coronary angioplasty: technique and complications. In: Topol EJ, ed. Textbook of Interventional Cardiology. 2d ed. Philadelphia: WB Saunders; 1994:201.
45. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-371.
46. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-623.
47. Hecht HS, Shaw RE, Bruce TR, et al. Usefulness of tomographic thallium-201 imaging for detection of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990; 66: 1314-1318.